SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

   Biotech / Medicalbiotech fireworks


Previous 10 Next 10 
To: tuck who wrote (2560)7/24/2006 3:16:20 PM
From: Ian@SI
   of 7424
 
PRAN up 60% on re-release of last week's PR on PBT2 - pre clinical Alzheimer's research. Was up about 80% earlier today.

Share RecommendKeepReplyMark as Last Read


To: scaram(o)uche who wrote (2559)7/24/2006 8:39:14 PM
From: dr.praveen
   of 7424
 
Thanks Rick...Your compliment gave me some goose bumps :-)

Share RecommendKeepReplyMark as Last Read


From: tuck7/25/2006 9:04:17 AM
   of 7424
 
OSCI up 24% premarket on inlicensing news:

Message 22653113

Cheers, Tuck

Share RecommendKeepReplyMark as Last ReadRead Replies (1)


To: tuck who wrote (2560)7/25/2006 9:51:16 AM
From: Saulamanca
   of 7424
 
MNTA up another 30%

MNTA Momenta Pharma and Sandoz sign exclusive collaboration to develop complex generics and follow-on versions of biotechnology drugs

Co announces an exclusive collaboration with Sandoz, the generics business of Novartis (NVS), to develop four follow-on and complex generic versions of previously approved recombinant biotechnology and complex drugs. As part of the collaboration, Sandoz will make an initial payment of $75 mln to the co for the purchase of approx 4.7 mln shares at a price of $15.93 per share, a 30% premium to the trailing 30-day average. The co is also eligible to receive up to $188 mln in additional payments if all milestones are achieved for the four product candidates. The collaboration will include one late-stage compound from the co's pipeline and two late-stage compounds from Sandoz.

Share RecommendKeepReplyMark as Last ReadRead Replies (1)


To: Saulamanca who wrote (2564)7/25/2006 10:04:58 AM
From: tuck
   of 7424
 
And may we say it's about time! They've been promising a deal for a good while now. Since my MNTA position is much larger than my ENCY position, it sure takes the sting out of the latter's setback.

Cheers, Tuck

Share RecommendKeepReplyMark as Last ReadRead Replies (2)


To: tuck who wrote (2565)7/25/2006 10:11:48 AM
From: Robohogs
   of 7424
 
Same here! Came into today grimacing and now I feel much better. Nice seeing the short covering in some other bios (un-named here as only up 5-10%).

Not sure what impact is on charity portfolio as both are there.

Jon

Share RecommendKeepReplyMark as Last Read


To: tuck who wrote (2565)7/25/2006 10:21:52 AM
From: Saulamanca
   of 7424
 
It`s not often you get the number one percentage loser and the number one percentage gainer on the same day.

Share RecommendKeepReplyMark as Last Read


To: scaram(o)uche who wrote (2559)7/25/2006 10:48:54 AM
From: sjemmeri
   of 7424
 
I know this is the wrong thread but I think you can give that Biotech Investor of the Year committee the rest of the year off.

steve

Share RecommendKeepReplyMark as Last ReadRead Replies (1)


To: sjemmeri who wrote (2568)7/25/2006 10:58:23 AM
From: scaram(o)uche
   of 7424
 
Nice comment.

Doc P., see how much your contributions have meant to S.I.?

We needed a good kick in the butt, eh Steve?

:-)

Best! Rick

Share RecommendKeepReplyMark as Last ReadRead Replies (2)


To: scaram(o)uche who wrote (2569)7/25/2006 11:54:37 AM
From: sjemmeri
   of 7424
 
The amazing thing to me is that he's only peoplemarked 15 times. Sorry if we've gone OT for too long on this thread.

Share RecommendKeepReplyMark as Last ReadRead Replies (1)
Previous 10 Next 10